Should I Buy SUSRF Stock in 2026?
Data-driven analysis and honest assessment for Surgical Science Sweden AB (publ)
Current Price: $2.84P/E: 20.3
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Fair P/E of 20.3
Declining -0%
Thin margins (0% net)
Financial health data limited
Excellent FCF yield of 90.6%
No recent insider activity
Key Investment Metrics
Current Price
$2.84
P/E Ratio
20.29
Revenue Growth
0.1%
Profit Margin
0.1%
Market Cap
$0.2B
Dividend Yield
None
How SUSRF Compares to Competitors
Understanding how SUSRF stacks up against peers helps inform your investment decision.
How SUSRF Compares to Peers
Upcoming Events for SUSRF
+5 Reasons TO Buy SUSRF
1. High free cash flow yield of 90.6%
strongFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
2. High gross margins of 67%
moderateGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy SUSRF
1. Thin profit margins of 0.1%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
3. Minimal revenue growth
low riskGrowth of 0.1% barely keeps pace with inflation.
Who Should Buy SUSRF?
Investment Profile
Risk Level
Very High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in SUSRF, compare these Healthcare peers:
Pro tip: Compare SUSRF directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for SUSRF
Frequently Asked Questions
What is SUSRF stock price today?
SUSRF (Surgical Science Sweden AB (publ)) stock is trading at $2.84 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is SUSRF stock going up or down today?
SUSRF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy SUSRF stock now?
The decision to buy SUSRF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is SUSRF a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for SUSRF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is SUSRF stock overvalued or undervalued?
SUSRF currently trades at a P/E ratio of 20.29 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if SUSRF is fairly priced.
What is SUSRF's P/E ratio?
SUSRF has a price-to-earnings (P/E) ratio of 20.29, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is SUSRF's market cap?
SUSRF (Surgical Science Sweden AB (publ)) has a market capitalization of $0.15 billion, making it a small-cap stock.
What is SUSRF's price to book ratio?
SUSRF trades at a price-to-book (P/B) ratio of 0.31, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Surgical Science Sweden AB (publ)
Full Stock Analysis
Complete SUSRF overview with charts and data
Is SUSRF Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how SUSRF stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Surgical Science Sweden AB (publ)
Complete SUSRF Analysis
Compare SUSRF With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.